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A B S T R A C T
Conditioned medium (CM) derived from engineered cells often facilitates the cost-eﬀective culture of a variety of
stem cells. Growing emphasis on the importance of rigor and reproducibility in lab-based science requires de-
velopment of best practices approaches, including quality control procedures for the assessment of CM batches to
ensure reliable interpretation and reproducibility. Here, we tested activity level variations of L-WRN CM, which
is produced from an L cell line engineered to secrete Wnt3a, R spondin 3, and Noggin into a single CM that is
widely used for gastrointestinal stem cell culture. We assessed 14 independent batches of L-WRN CM, produced
by 5 laboratories at 3 research institutions, by multiple quantitative assays. We observed highly replicable ac-
tivity levels among L-WRN CM batches prepared according to a previously published protocol. Quality control
assays measuring spheroid growth or mRNA gene marker expression were best able to distinguish the quality L-
WRN CM batches, whereas a Wnt reporter assay did not. Thus, we have validated that L-WRN CM activity is
highly reproducible over time and between laboratories and have provided guidelines for L-WRN CM quality
control testing. These validation procedures and guidelines will beneﬁt experiment replication eﬀorts in stem
cell research.
Key resources table
Reagent or resource Source Identiﬁer
Antibodies
Bacterial and Virus Strains
Biological Samples
Chemicals, Peptides, and Recombinant Proteins
Y-27632 R&D Systems Cat #1254
SB 431542 R&D Systems Cat #1614
L-161,982 R&D Systems Cat #2514




Recombinant carrier-free TNF (h-
uman)
Biolegend Cat #570102
Recombinant carrier-free TNF (m-
ouse)
Biolegend Cat #575202
Recombinant Wnt3a R&D Systems Cat.# P27467
Critical Commercial Assays
LookOut Mycoplasma PCR Detect-
ion Kit
Sigma Cat #MP0035
CellTiter-Glo® 3D Cell Viability A-
ssay
Promega Cat #G9681





ONE-Step™ Luciferase Assay Syst-
em
BPS Bioscience Cat #60690–2
Deposited Data
Experimental Models: Cell Lines
L-WRN cells ATCC Cat #CRL-3276;
RRID:CVCL_DA06
Cdc25A-CBRLuc murine colonic s-
pheroid line
Sun et al., 2015 N/A
HEK293 TCF/LEF-reporter recom-
binant cell line
BPS Bioscience Cat #60501
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Organoids derived from pluripotent or adult tissue stem cells can be
cultured to model gastrointestinal epithelium. These primary cultures
generally contain the mitotic stem and progenitor cells as well as the
post-mitotic diﬀerentiated cell types normally present in the in vivo
tissue. Consequently, organoid culture methods have quickly gained
traction in the scientiﬁc community for basic and translational research
studies of gastrointestinal physiology and pathophysiology (Clevers,
2016; Miyoshi, 2017; Nakamura and Sato, 2018). In order to derive
organoids from adult tissue stem cells, the culture conditions must
contain components of the stem cell niche (Clevers, 2016). Intestinal
organoids form and are maintained when the stem cells are embedded
in an extracellular matrix (e.g. Matrigel) and are provided with medium
containing 3 necessary protein factors, Wnt3a, R spondin 1, 2, or 3, and
Noggin (Sato et al., 2009). These factors can be delivered as re-
combinant proteins or via conditioned medium (CM) from other cell
lines engineered to secrete these proteins individually or in combina-
tion (Sato et al., 2009; Heijmans et al., 2013; Miyoshi and Stappenbeck,
2013; Ootani et al., 2009; Wen et al., 2017; Wang et al., 2013). Media
composition and the delivery method of stem cell niche factors can alter
the cellular composition and behavior of the cultured epithelial cells in
downstream assays.
The National Institutes of Health, leading scientitic journal editorial
boards, and others in the scientiﬁc community are calling for increased
transparency, rigor, and reproducibility in experimental science
(Collins and Tabak, 2014; Jackson, 2015; McNutt, 2014). This appeal is
due in part to reports of cell line cross-contamination and lax validation
of key biological reagents leading to erroneous experiment results,
wasted time and resources, and diminished public trust in science
(Freedman et al., 2015; Baker, 2016). A major action item from these
appeals is the incorporation of rigorous procedures to authenticate and
validate reagents that could diﬀer over time within a single laboratory
or between laboratories (Collins and Tabak, 2014; Jarvis and Williams,
2016). Related to this issue, there is a call for increased transparency in
reporting the authentication and validation procedures used by in-
vestigators to improve interpretation and replication of scientiﬁc ﬁnd-
ings. The CM used for primary intestinal stem cell culture represents
one such key biological reagent that could diﬀer over time or between
laboratory groups, and thus it should be subjected to rigorous quality
control procedures. Furthermore, the quality control methods and re-
sults should be reported to the scientiﬁc community.
The Stappenbeck laboratory previously developed a CM cell line,
referred to as the L-WRN cell line. L-WRN cells are L cells that secrete
Wnt3a, R spondin 3, and Noggin into a single CM (Miyoshi et al., 2012).
The L-WRN CM is a specialized biological reagent used to culture epi-
thelial cells from multiple endodermal tissues of a variety of mammals,
including mouse and human gastrointestinal epithelial stem cells
(Miyoshi and Stappenbeck, 2013; VanDussen et al., 2015; Aly et al.,
2013; Powell and Behnke, 2017). Intestinal stem cells embedded in
Matrigel and provided with L-WRN CM will form nearly spherical, non-
budding three-dimensional structures that have an inner lumen and are
comprised of nearly all mitotic stem and progenitor cells (Miyoshi and
Stappenbeck, 2013; Miyoshi et al., 2012; VanDussen et al., 2015).
These structures have been termed spheroids to distinguish them from
the budding structures termed organoids, enteroids, or colonoids,
which are comprised of a mixture of proliferating and post-mitotic
epithelial cells (Stelzner et al., 2012). Because spheroids are highly
enriched for proliferating cells, they expand at a relatively rapid rate to
facilitate suﬃcient production of cells for use in downstream assays,
including Transwell culture (VanDussen et al., 2015; Moon et al.,
2014). Replacement of the L-WRN CM with a diﬀerentiation medium
promotes formation of mature epithelial cell lineages, such as en-
terocytes, colonocytes, goblet cells, or wound-associated epithelial cells
(Kaiko et al., 2016; Miyoshi et al., 2017; Patel et al., 2013). Dilution of
the L-WRN CM can also promote formation of post-mitotic cells
(VanDussen et al., 2015). Because the concentration (i.e. activity) of the
L-WRN CM can aﬀect cell state, it is critical to assess batch-to-batch
activity levels. In addition, the L-WRN cell line is now being used by
laboratories across the world, underscoring the need to investigate L-
WRN CM batch-to-batch variation to ensure that experiments using this
medium are reproducible within and between laboratories.
We surmised that L-WRN CM activity could be inﬂuenced by vari-
ables such as passage-to-passage behavioral shifts of the L-WRN cell
line, medium storage time at 4 °C, L-WRN CM collection period diﬀer-
ences, and slight technical variations in the L-WRN CM production
process that potentially occur within or between laboratories. Taking
these into account, we undertook an investigation of the variation in L-
WRN CM activity levels using 14 batches of L-WRN CM produced by 5
laboratories across 3 research institutions. As a secondary objective, we
sought to identify experimental assays that could discrimate the quality
L-WRN CM batches in order to provide a framework for L-WRN CM
quality control procedures to laboratories utilizing this key biological
resource. Overall, this study showed that L-WRN CM activity was highly
replicable across laboratory groups when the CM protocol was properly
executed. This led us to conclude that L-WRN CM will enable faithful
reproduction of spheroid culture experiments over time and between
laboratory groups.
2. Materials and methods
2.1. Culture and authentication of L-WRN cells
L-WRN cells (ATCC®; Cat.# CRL-3276™) were cultured in high
glucose DMEM (Sigma-Aldrich, Cat.# D5796) supplemented with pe-
nicillin (100 units/mL), streptomycin (0.1 mg/mL) (Sigma-Aldrich,
Cat.# P4333) and 10% fetal bovine serum (Sigma-Aldrich, Cat.#
F2442) (Fig. S1A) (Miyoshi et al., 2012). Mycoplasma infection
screening was performed with the LookOut Mycoplasma PCR Detection
kit (Sigma-Aldrich, Cat.# MP0035) as recommended by the manu-
facturer using cultured L-WRN cell supernatant (Dobrovolny and Bess,
2011). For species validation of the L-WRN line, PCR ampliﬁcation of
the mitochondrial cytochrome C oxidase I (COI) gene, which is highly
conserved within a species but highly variable between species, was
performed using published primer sets (Cooper et al., 2007). Genomic
DNA template for species validation was isolated from cultured L-WRN
cells using the QIAamp DNA Mini Kit (Qiagen; Cat.# 51304). Genomic
DNA was isolated from mouse and human intestinal epithelial spheroids
to use as controls. For the genomic DNA isolation, 200 μL of Buﬀer ATL
and 20 μL of Proteinase K was added to cell pellets suspended in
~200 μL of PBS followed by incubation for 3 h at 56 °C. Next, 200 μL of
Buﬀer AL was added and the mixture was incubated for 10min at 70 °C.
Subsequent steps followed the manufacturer's directions, with 100 μL of
Buﬀer AE used for elution. Sample concentrations were determined
using a Cytation5 Multi-mode Reader (BioTek). PCR reactions used 2×
JumpStart™ REDTaq® ReadyMix™ Reaction Mix (Sigma, Cat No.
P0982), 0.4 μM ﬁnal concentration of Homo sapiens primers (Hs-F and
Hs-R), 0.6 μM ﬁnal concentration ofMus musculus primers (Mmus-F and
Mmus-R), and 10 ng of genomic DNA template. Cycling conditions were
as follows: one cycle of 94 °C for 2min; 35 cycles of 94 °C for 30 s, 60 °C
for 30 s and 72 °C for 45 s; one cycle of 72 °C for 5min; indeﬁnite hold
at 4 °C. Products were visualized using a 2% agarose gel stained with
ethidium bromide. Expected product lengths were 391 bp for Homo
sapiens and 159 bp for Mus musculus.
2.2. Production of L-WRN conditioned medium
The protocols for small-scale and large-scale L-WRN conditioned
medium (L-WRN CM) production have been previously described
(Miyoshi and Stappenbeck, 2013) (also see Fig. S1B). With the large-
scale protocol, a Nunc™ EasyFill™ Cell Factory™ 10 (Fisher Scientiﬁc) is
used to produce 16 L of 50% L-WRN CM over 8 days, with 8 L being
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produced during Days 1–4 and another 8 L being produced during Days
5–8.The 50% L-WRN CM is a 50/50 mix of the CM and fresh primary
culture media, which is Advanced DMEM/F-12 (Invitrogen; Cat.#
12,634–010) supplemented with 20% fetal bovine serum (Sigma-Alrich;
Cat.# F2442), 2 mM L-glutamine, 100 units/mL penicillin and 0.1 mg/
mL streptomycin. All experiments in this study used 50% L-WRN CM,
unless indicated otherwise, that was aliquoted and stored at −20 °C or
−80 °C for 0–8months (CM1-13 and technical error (TE) batches were
stored for 4–8months at the time of testing). During L-WRN CM pro-
duction for the TE batch, the incorrect volume of primary culture
medium was added to the cell factory; reagent composition and all
other performed procedures were equivalent between the TE and CM1-
13 batches.
2.3. Intestinal epithelial spheroid culture
Colonic crypts were isolated from adult mouse or human rectal
tissue and grown as three-dimensional spheroids in Matrigel as pre-
viously described (Miyoshi and Stappenbeck, 2013; VanDussen et al.,
2015). The collection and use of human intestinal tissue for spheroid
culture was approved by the Institutional Review Board of Washington
University School of Medicine and written informed consent was ob-
tained from the donor prior to inclusion in the study. Spheroids were
maintained as enriched for stem and progenitor cells by culturing in L-
WRN CM. For mouse spheroid culture, 10 μM Y-27632 (ROCK inhibitor;
R&D Systems, Cat.# 1254) was added to the medium provided im-
mediately upon passage. For human spheroid culture, the L-WRN CM
was supplemented with 10 μM Y-27632 and 10 μM SB 431542 (TGF-βRI
inhibitor; R&D Systems, Cat.# 1614) (VanDussen et al., 2015). To in-
duce colonocyte diﬀerentiation, mouse and human spheroids were
cultured for 36–48 h in diﬀerentiation medium, which is primary cul-
ture medium lacking serum and supplemented with 50 ng/mL EGF
(Peprotech, Cat.# 315-09B), 10 μM Y-27632, and 10 μML-161, 982
(EP4 inhibitor; R&D Systems, Cat.# 2514), as previously described
(Kaiko et al., 2016; Miyoshi et al., 2017). For general maintenance,
spheroids were passaged and embedded into Matrigel on Day 0,
medium was changed on Day 2, and spheroids were passaged again on
Day 3 or 4. For experiments, a minimum of 3 independent experiments
were performed with distinct passages of spheroids (ranging from
passage 8–15) for each assay (i.e., n≥ 3 biological replicates per con-
dition per assay). All of the L-WRN CM test batches and the appropriate
controls were assessed concurrently within each experiment.
2.4. Imaging of cultured cells and determination of spheroid area
Live cultures of L-WRN cells and spheroids were imaged with a
Pupil Cam camera (Ken-a-Vision) ﬁxed to a phase microscope (Fisher
Scientiﬁc) equipped with LPL4/0.10 4×, PH10X/0.25, and LWD
PH20X/0.40 objective lenses. Adobe Photoshop CS6 was used to con-
vert images to grayscale, adjust brightness and contrast, and crop
images. Spheroid area was measured using ImageJ (Schneider et al.,
2012), as described previously (VanDussen et al., 2015). The area of
52–70 spheroids was measured and averaged per condition for each of
3 independent experiments.
2.5. CellTiter-Glo assay
Spheroids were seeded into white-walled 96-well plates, with 5 μl
droplets of spheroid-Matrigel mixture and 100 μL of L-WRN CM per
well. For mouse spheroids, Day 3 spheroids in 1 well of a 12-well plate
were used to seed ~12 wells of a 96-well plate. For human spheroids,
Day 3 spheroids in 1 well of a 12-well plate were used to seed ~8 wells
of a 96-well plate. Medium was changed daily. The CellTiter-Glo® 3D
Cell Viability Assay (Promega; Cat.# G9681) was used to assess
spheroid growth and viability on Day 3 of culture according to the
manufacturer's directions. Luminescence was detected using a
Cytation5 Multi-mode Reader (BioTek). Culture wells containing L-
WRN CM and CellTiter-Glo® reagent but without spheroids were used to
determine the average background luminescence. For control wells
containing spheroids induced to undergo cell death, 50 μg/mL cyclo-
heximide (CHX; Enzo Life Sciences) and 100 ng/mL recombinant car-
rier-free mouse or human tumor necrosis factor (TNF; Biolegend) were
added 15 h prior to addition of the CellTiter-Glo reagent. Assays were
performed with quadruplicate technical replicates, which were aver-
aged prior to statistical analysis, for three independent experiments
with distinct passages of spheroids.
2.6. Cdc25A-CBR luciferase assay
Analysis of proliferation with the Cdc25A-CBRLuc murine colonic
spheroid line has been previously described (Kaiko et al., 2016; Sun
et al., 2015). Assays were performed with quadruplicate technical re-
plicates, which were averaged prior to statistical analysis. Data for each
of three independent experiments were normalized to the average time
0 h value of all samples within each experiment. As a control, 1 mM of
butyrate was added to the L-WRN CM in some wells.
2.7. LDH assay
The Pierce™ LDH Cytotoxicity Assay Kit (Thermoﬁsher Scientiﬁc;
Cat.# 88953) was used to assess cellular cytotoxicity according to
manufacturer's directions using L-WRN CM alone or the medium su-
pernatant from spheroid cultures. A Cytation5 Multi-mode Reader
(BioTek) was used to measure the absorbance at 490 nm and 680 nm of
each well. The A680 nm value (background signal from the instrument)
was subtracted from the A490 nm value to determine the LDH activity.
The LDH positive control (LDH+) was included with the kit. For L-
WRN CM without exposure to cultured spheroids, the LDH assay was
performed with quadruplicate technical replicates, which were aver-
aged prior to statistical analysis, in three independent experiments with
distinct assay reaction mixtures. For L-WRN CM with exposure to cul-
tured spheroids, assays were performed with quadruplicate technical
replicates, which were averaged prior to statistical analysis, for three
independent experiments with distinct passages of spheroids.
2.8. RNA isolation and qPCR analysis
Total RNA was puriﬁed from 1-well of a 12-well plate of cultured
spheroids on Day 3 post-seeding using the NucleoSpin RNA II kit
(Machery-Nagel, Duren, Germany). Sample concentration was de-
termined using a Cytation5 Multi-mode Reader (BioTek). For quanti-
tative reverse transcription PCR (qPCR), cDNA was synthesized using
1 μg of total RNA and the iScript™ Reverse Transcription Supermix (Bio-
Rad: Cat.# 1708841). Quantitative PCR reactions used technical du-
plicates for each of three biological replicates per experimental condi-
tion and contained SYBR Advantage qPCR Premix (Clontech; Cat.#
639676), 200 nM of each primer, and 40 ng cDNA. A BioRad CFX
Connect Real-time System Thermocycler was used with the following
cycling parameters: 1 cycle of 95 °C for 2min; 40 cycles of 95 °C for 10 s,
60 °C for 20 s and 72 °C for 30 s; 1 cycle of 72 °C for 5min; melting curve
analysis over a temperature range of 95 °C to 60 °C; indeﬁnite hold at
4 °C. Primers were synthesized at Sigma-Aldrich. All primer pairs were
validated to have an eﬃciency of 100% ± 10% over a range of cDNA
concentrations and to generate a single product by agarose gel analysis
and Sanger sequencing. Primer sequences are listed in Supplementary
Table 1. Relative gene expression levels were determined with the
ΔΔCT method and the housekeeper gene glyceraldehyde 3-phosphate
dehydrogenase (Gapdh), which was expressed at similar levels in all
samples. Technical repeats were averaged prior to determine the
average ΔCT value for each sample. The average of these ΔCT values for
the Stappenbeck L-WRN CM batches (CM1–7) was used to calculate the
ΔΔCT values.
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2.9. Wnt reporter assay
The HEK293 TCF/LEF-reporter recombinant cell line (BPS
Bioscience; Cat.# 60,501) was cultured according to the vendor's re-
commendations. To avoid detachment of the reporter cells from the
culture well surface, L-WRN CM or primary culture medium was care-
fully added at 1:1 vol/vol to the existing HEK293 medium in the culture
well for this assay. Viability in the 1:1 medium mixtures was de-
termined using the CellTiter-Glo® 3D Cell Viability Assay, as described
above. Recombinant Wnt3a (R&D systems; Cat.# P27467) was used as a
positive control. L-WRN CM batches were tested at a ﬁnal concentration
of 5% (i.e., added 10% L-WRN CM at a 1:1 vol/vol to the HEK293
medium) for Wnt activity assays. Luciferase activity was determined
using the ONE-Step™ Luciferase Assay System (BPS Bioscience; Cat.#
60690-2) and luminescence was measured with a Cytation5 Multi-mode
Reader (BioTek). Culture wells containing L-WRN CM and ONE-Step™
reagent but without cells were used to determine the average back-
ground luminescence. Culture wells containing cells, and
HEK293:primary culture medium (1:1) were used to determine baseline
reporter activity. Experiments included 3 technical replicates, and 3
biological experiments with distinct passages of cells were performed.
Technical replicates from each experiment were averaged prior to sta-
tistical analysis.
2.10. Statistics
Statistical analysis was performed using GraphPad Prism software
(version 7) and parametric tests, as data were determined to be of a
normal distribution or were of insuﬃcient sample size to determine
normal distribution. A 2-way repeated measures ANOVA was used to
assess Cdc25A-CBRLuc data. Comparison of 2 groups (Supplementary
Figs. S4, S5, and S6) were analyzed using an unpaired, two-tailed t-test.
Comparisons of> 2 groups were analyzed using a 1-way ANOVA fol-
lowed by a Dunnett's multiple comparisons post-test with either the
0WK condition (Fig. 2) or average Stappenbeck media values (average
results from CM1-7; Figs. 3–7) set as the control condition, unless
otherwise stated in the ﬁgure legend. P < 0.05 was considered to be
signiﬁcant.
2.11. Key resource table
Key resource information is provided in a separate table.
3. Results
3.1. Authentication of the L-WRN cell line
Authenication of the L-WRN cells is a critical initial step in quality
control testing of L-WRN CM. To maintain low passage cells and
minimize variations that could aﬀect L-WRN CM activity as well as
downstream applications with intestinal epithelial cells, we prepare
large lots of L-WRN cell line stocks for cryogenic storage (i.e. 64 vials
per preparation) (Fig. S1A). We randomly recovered 1 cryogenic vial of
L-WRN cells out of this lot and performed authentication procedures for
mouse cell lines, consisting of species veriﬁcation, determination that
the cell line is free from mycoplasma, and phase contrast microscopy to
conﬁrm the morphology and growth pattern of the cells over multiple
days of culture (Freedman et al., 2015; Cooper et al., 2007; Shannon
et al., 2016). We veriﬁed that the lot of L-WRN cells used in this study
was of mouse origin (Fig. 1A) and free of mycoplasma contamination
(Fig. 1B) using PCR-based assays. Microscopic assessment of L-WRN cell
morphology conﬁrmed that all cells displayed a characteristic ﬁbroblast
appearance (Fig. 1C). At 24 h post-thaw, the L-WRN cells were adherent
but only a portion exhibited an elongated shape. By 48 h post-thaw, the
majority of the L-WRN cells exhibited an elongated shape and were
bipolar or multipolar. L-WRN cells should typically be subcultured at
80–90% conﬂuency (e.g. when preparing frozen stocks), but for L-WRN
CM production, it is important to culture L-WRN cells until they are
post-conﬂuent, with some cells becoming detached from the culture
surface, prior to beginning collection of L-WRN CM (Fig. 1C).
3.2. Sustained activity of L-WRN CM following freeze-thaw
Freeze-thaw cycles and longer storage periods at 4 °C are associated
with protein degradation (Cao et al., 2003). Therefore, we tested how
varying the length of 4 °C storage periods or one additional freeze-thaw
cycle aﬀected L-WRN CM support of stem cell spheroid growth and
proliferation. We stored aliquots of a single batch of L-WRN CM for 0, 1,
2, or 3 weeks at 4 °C (0WK, 1WK, 2WK, 3WK, respectively). We also
thawed a single L-WRN aliquot and divided it into two portions, one of
which served as a control (2XFT Cont) and the other was subjected to a
second freeze-thaw cycle (2XFT). Mouse colonic spheroids were cul-
tured in these six media conditions followed by assessment of spheroid
growth, stem cell activity, and proliferation (Fig. 2). Spheroids cultured
in these media exhibited similar growth as determined by CellTiter-Glo,
a luminescent assay that detects ATP present in live cells (Fig. 2A, B). As
negative controls for spheroid growth, we treated cells with CHX and
recombinant TNF to induce cell death or changed the medium to induce
to post-mitotic colonocytes (Kaiko et al., 2016; Miyoshi et al., 2017).
To determine whether these media preparations similarly supported
the maintenance of proliferative stem and progenitor cells, we assessed
mRNA gene expression of the intestinal stem cell marker Lgr5 (Barker
et al., 2007), the proliferative cell marker MKi67 (Gerdes et al., 1983;
Sobecki et al., 2016), the Wnt reporter gene Axin2 (Jho et al., 2002;
Kim et al., 2007), and the colonocyte diﬀerentiation marker Car1
(Parkkila et al., 1994) by qPCR (Fig. 2A, C). The markers associated
with proliferative cells (Lgr5, MKi67, and Axin2) were highly expressed
in spheroids cultured in L-WRN CM regardless of media storage length
or additional freeze-thaw compared to the diﬀerentiated colonocyte
spheroids. In contrast, Car1 mRNA was only highly expressed in colo-
nocyte spheroids. Only spheroids cultured in 3WK medium (media at
4 °C for 3 weeks) exhibited a statistically signiﬁcant increase in MKi67
mRNA expression relative to 0WK medium. This pattern is reminiscient
of the small increase in the frequency of EdU-positive proliferating cells
previously observed in spheroids cultured in 5% L-WRN CM (a 10-fold
reduction of the L-WRN CM concentration that optimally supports
spheroid growth) (VanDussen et al., 2015). This ﬁnding suggests re-
duced potency of L-WRN media when it is maintained at 4 °C for
3 weeks.
To directly assess spheroid proliferation, we used a mouse colon
spheroid line derived from a Cdc25A-click beetle red luciferase cell
cycle reporter mouse (Sun et al., 2015). The luminescence of Cdc25A-
luciferase spheroids faithfully correlates with cell proliferation (Kaiko
et al., 2016; Sun et al., 2015). When spheroids were cultured in L-WRN
CM, luminescence increased over a 24-hr period, concomitant with
spheroid proliferation and growth (Fig. 2D, E). The addition of the
short-chain fatty acid butyrate to L-WRN CM signiﬁcantly halted
spheroid proliferation, similar to our previous report (Kaiko et al.,
2016). We did not observe a statistical diﬀerence between 0WK and any
other L-WRN CM based on storage time or additional freeze-thaw cycle;
however, proliferation trended lower in the 3WK vs. 0WK media. Col-
lectively, these experiments demonstrated that L-WRN CM activity was
sustained and remained relatively stable when stored at 4 °C for up to
several weeks or subjected to one additional freeze-thaw. Because we
observed some signs of diminished L-WRN CM activity with the 3WK
storage condition, we performed all subsequent experiments using
media stored at 4 °C no longer than 2weeks post-thaw.
3.3. Highly reproducible spheroid growth across multiple L-WRN CM
batches
Next, to assess the batch-to-batch variation of L-WRN CM, we
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gathered 14 batches of L-WRN CM produced according to the same
protocol and then stored at −20 °C or −80 °C for 4 to 8months
(Fig. 3A) (Miyoshi and Stappenbeck, 2013). Of these L-WRN CM bat-
ches, 7 had been produced in the Stappenbeck laboratory, 3 had been
produced by two collaborater laboratories at Washington University,
and 4 had been produced by two collaborator laboratories at other
institutions. During the production of one of these L-WRN CM batches,
a technical error (TE) occurred (see Methods), but we still incorporated
this TE batch into our study as a potential negative control. Of the 13
correctly produced batches, 8 were collected on Days 1–4 and 5 were
collected on Days 5–8. Of the 7 batches produced by the Stappenbeck
laboratory, 3 were produced by large teams consisting of ~15 people
and 4 were produced by small teams consisting of ~5 people. Together,
these L-WRN CM batches allowed us to test a number of variables for
potential eﬀects on CM activity: 1) CM collection on Days 1–4 vs. Days
5–8 of CM production, 2) CM collection across diﬀerent laboratories; 3)
CM collection by large vs. small teams. Mouse or human colonic
spheroids were initially passaged and expanded for downstream assays
using a single batch of L-WRN CM to ensure equivalency prior to cul-
ture in one of the 14 L-WRN CM test batches (Fig. 3B). Spheroids ap-
peared qualitatively similar when cultured in any of CM1-13 (Fig. 3C,
Figs. S2, S3). Mouse spheroids cultured in L-WRN CM had a spherical
shape, a clear lumen, and thin, smooth edges. In contrast, diﬀerentiated
spheroids appeared darker due to their smaller lumen and thicker walls.
Budding structures, which are typically observed with intestinal orga-
noid culture methods (Sato et al., 2009), were absent in both pro-
liferative and diﬀerentiated spheroids. Similar features were observed
in the human spheroids, except these were often “clumpy” in appear-
ance, with a less apparent lumen. We measured the average two-di-
mensional area of the spheroids cultured in each L-WRN CM test batch
and conﬁrmed that the spheroid size was similar following culture with
CM1–13 within each species (Fig. 3D, E). The human spheroids were
smaller than the mouse spheroids, reﬂective of their lower growth rate
(VanDussen et al., 2015; Kaiko et al., 2016; Sun et al., 2015). Following
culture with the TE batch, very few spheroids were still apparent and
those remaining tended to be signiﬁcantly smaller than those cultured
with CM1-13. Quantitative assessment of spheroid growth using the
CellTiter-Glo assay supported these ﬁndings, with similar growth ob-
served in spheroids cultured with CM1-13 batches and greatly reduced
growth in spheroids cultured with the TE batch (Fig. 4A–B). These re-
sults indicate that the TE batch did not support spheroid growth. We did
not observe diﬀerences in spheroid size or growth based on the CM
collection period (Fig. S4A, B) or production laboratory (Fig. S5A, B).
However, spheroid growth was slightly, but signiﬁcantly, elevated in
Fig. 1. Authentication of L-WRN cells.
(A, B) Representative images of ethidium bromide-stained agarose gels showing PCR products from species validation assay (A) or mycoplasma detection assay (B).
Band sizes for the DNA ladder and expected PCR products are indicated in base pairs (bp). (A) L-WRN cells were purely of mouse origin. As controls, mouse and
human spheroid gDNA were used as template either singly or mixed. NT, no template control. (B) Two independent samples from L-WRN cells were determined to be
mycoplasma-free. Postive (Pos) and negative (Neg) controls were included in the kit. (D) Representative low- and high-power magniﬁcation images of L-WRN cells at
the indicated times post-seed demonstrating the ﬁbroblast characteristics of this cell line. Scale bars, 100 μm.
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mouse spheroids when cultured in the CM produced by small teams
rather than large teams in the Stappenbeck lab (Fig. S6A, B).
Because CellTiter-Glo results were similar between the spheroids
cultured in the TE batch and those purposely induced to undergo cell
death, we examined whether the TE batch led to spheroid cell death
using a colorimetric assay for lactate dehydrogenase (LDH), which is
released into media by damaged cells (Fig. 4C–D). LDH levels in
spheroid culture supernatants were generally very low. We did not
detect increased LDH in the supernatant of spheroids cultured in the TE
batch, indicating that cell death or toxicity was likely not the reason for
the diminished spheroid growth. However, we found very high levels of
LDH in the CM10 spheroid supernatants. Because the CM10-cultured
spheroids appeared to be growing normally, we performed the LDH
assay using CM alone (i.e., no exposure to spheroids) (Fig. 4E). Elevated
LDH levels were observed in the CM10 medium itself. This could be due
to insuﬃcient removal of L-WRN cells from the ﬁnal CM during the
collection process, which could result in L-WRN cell damage and LDH
release during freeze-thaw of the L-WRN CM.
3.4. Highly reproducible mRNA gene marker expression across multiple L-
WRN CM batches
We next used our qPCR gene marker panel to determine whether the
L-WRN CM batches similarly supported the maintenance of pro-
liferative stem and progenitor cells. Expression levels of the Lgr5 stem
cell and MKi67 proliferative cell markers were similar across the
CM1–13 batches, but were very low or undetectable with the TE batch
(Fig. 5A, B). Axin2 mRNA expression was similar between spheroids
cultured with CM1–13 and the TE medium, with Axin2 mRNA even
being signiﬁcantly higher in the human spheroids cultured in TE vs.
CM1–13 (Fig. 5C). This was surprising, as Wnt signaling is the critical
pathway supporting intestinal stem cells (Miyoshi, 2017; Kretzschmar
and Clevers, 2017); these data indicate that the Wnt-stimulating ac-
tivity of the TE batch is not diminished, and yet it did not support
spheroid growth. The colonocyte marker Car1 was expressed at low
levels in spheroids cultured with CM1–13, but highly expressed in
spheroids cultured with the TE medium (Fig. 5D). Thus, the TE medium
robustly stimulated spheroid diﬀerentiation to post-mitotic colono-
cytes, accounting for its deﬁciency in supporting spheroid growth. We
did not observe any signiﬁcant diﬀerences in the expression of these
genes based on batch collection period (Fig. S4C–F), production la-
boratory (Fig. S5C–F), or production team size, other than signiﬁcantly
higher Car1 mRNA expression in mouse spheroids cultured in medium
produced by large teams relative to small teams (Fig. S6C–F).
Fig. 2. L-WRN CM activity is maintained over several weeks of storage following thaw.
(A-E) L-WRN CM was stored at 4C for 0WK, 1WK, 2WK, 3WK or subjected to a second freeze-thaw cycle (2XFT). An aliquot of the 2XFT sample was removed prior to
the second freeze-thaw cycle to serve as a direct control (2XFT Cont). Spheroids cultured in diﬀerentiation medium with EP4 inhibitor (DM+EP4i), treated with
cycloheximide and tumor necrosis factor (CHX+TNF), or treated with butyrate served as negative controls. (A) Schematic of experimental time line for assays in (B)
and (C). (B) Graph of CellTiter-Glo data presented as fold change (mean ± s.e.m.) relative to DM+EP4i; n=3 independent experiments. ****P < 0.0001 by 1-
way ANOVA and Dunnett's post test relative to 0WK. (C) Graphs of mRNA gene expression for indicated genes as determined by qPCR. Data are presented as fold
change (mean ± s.e.m.) relative to 0WK; n= 3 independent experiments. (D) Schematic of experimental time line for (E). (E) Graph of Cdc25A-CBRluc data
normalized to the average 0 h value of all samples; n= 3 independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001 by 1-way ANOVA (B,
C) or by 2-way repeated measures ANOVA (E) using Dunnett's post test relative to 0WK (B, C, E).
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3.5. Highly reproducible proliferation across multiple L-WRN CM batches
We next directly assessed potential eﬀects of L-WRN CM batch-to-
batch variation in spheroid proliferation using Cdc25A-luciferase
spheroids (Fig. 6A, B). All of the L-WRN CM batches stimulated pro-
liferation to a similar degree (Fig. 6B). The TE batch did not exhibit
statistically diminished proliferation in this assay; however, the curve
generated by these data was uniquely high at the 0-hr time point and
then diminishing at the 16-hr time point compared to the other CM
batches. We did not observe any diﬀerences in the capacity of CM1-13
batches to drive spheroid proliferation based on collection period (Fig.
S4G), production laboratory (Fig. S5G), or production team size (Fig.
S6G).
3.6. L-WRN CM batches similarly activate a Wnt reporter cell line
Wnt is the key signaling pathway supporting renewal of the in-
testinal stem cell (Miyoshi, 2017; Kretzschmar and Clevers, 2017). The
Wnt ligand Wnt3a and the Wnt signaling potentiator R-spondin 3 are
key components of L-WRN CM that stimulate high levels of Wnt sig-
naling in the cultured spheroids (Sato et al., 2009; Miyoshi et al., 2012).
We hypothesized that testing L-WRN CM activity with HEK293 Wnt
(TCF/LEF) luciferase reporter cells would be an easy surrogate for the
degree to which L-WRN CM batches would support spheroid growth,
Fig. 3. Reproducible spheroid size across multiple L-WRN CM batches.
(A) Schematic of L-WRN CM batches included in the batch-to-batch reproducibility study, including CM1–13 and the technical error (TE) batch. CM batches were
collected at one of 3 institutional sites by the Stappenbeck laboratory or a collaborating laboratory (Collab1, Collab2, Collab3, Collab4). The Stappenbeck CM batches
were collected by large or small teams. CM batches collected on Days 1–4 and Days 5–8 are in the upper row and lower row, respectively. (B) Schematic of
experimental time line for the indicated assays. (C) Representative images from a single experiment of mouse and human colonic spheroids cultured in L-WRN CM,
colonocyte diﬀerentiation medium (DM+EP4i), or the TE batch. Scale bars, 200 um. (D, E) Graphs of mouse (D) and human (E) spheroid size expressed as the
average two-dimensional area (μm2; mean ± s.e.m.) from n=3 independent experiments. *P < 0.05 by 1-way ANOVA with Dunnett's post test relative to the
average Stappenbeck CM value (represented by dashed line; 11,444 μm2 for mouse spheroids and 5706 μm2 for human spheroids).
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such that high Wnt activity should directly correlate with enhanced
spheroid growth. The Wnt reporter cells were viable in 1:1 HEK
media:L-WRN CM (Fig. 7A). Stimulation of the reporter cells with 5% L-
WRN CM yielded a suitable dynamic range for detection of increases
and decreases in L-WRN CM Wnt activity (Fig. 7B). Wnt reporter in-
duction was similar between all of the L-WRN CM batches, including
the TE batch that did not support spheroid growth (Fig. 7C). These
results support the high expression of Axin2 mRNA in spheroids cul-
tured with the TE batch (Fig. 5). Wnt reporter induction was similar
between production laboratories (Fig. S5H) and production team sizes
(Fig. S6H), but was signiﬁcantly elevated in medium batches collected
on Days 1–4 vs. Days 5–8 (Fig. S4H), despite there being no eﬀect of
collection period on spheroid growth or proliferation (Fig. S4A, B, G).
Together, these ﬁndings indicate that the use of Wnt signaling readouts
does not discriminate between L-WRN CM medium batches that eﬃ-
ciently support spheroid growth and those that do not.
4. Discussion
Here, we applied multiple quality control approaches to test the
batch-to-batch reproducibility of 14 L-WRN CM batches produced by
several independent laboratories and institutions. The CM batches were
produced over a several month period by the Stappenbeck laboratory
and by collaborating research groups within our institution (i.e. re-
ceived hands-on training with the Stappenbeck laboratory) and at ex-
ternal institutions (i.e. did not train in person, but had access to the
same written protocol, which was clariﬁed via phone and email).
Importantly, these independently produced L-WRN CM batches were
nearly identical in supporting intestinal spheroid growth and pro-
liferation, with the exception of a single batch where a known technical
error had occurred. These data provide strong evidence that experi-
ments utilizing L-WRN CM to culture intestinal epithelial cells will yield
reproducible results over time and between laboratory groups when
proper quality control testing of the L-WRN CM is performed. This high
level of reproducibility is of great beneﬁt to the scientiﬁc community, as
there are numerous investigators currently using L-WRN CM to culture
primary gastrointestinal epithelial cells for studies related to re-
generative medicine and tissue engineering, host genetics and phy-
siology, host-microbiome interactions, tumorigenesis, and disease pa-
thogenesis (references provided in Table S2).
A principal challenge in determining the quality of a particular
batch of CM (L-WRN or otherwise) using organoid- or spheroid-based
Fig. 4. Reproducible spheroid growth across multiple L-WRN CM batches.
(A-D) Mouse (A, C) or human (B, D) spheroids were cultured in CM1–13 or TE batches of L-WRN CM followed by assessment of cell growth with the CellTiter-Glo
assay (A, B) or cell death with the LDH assay (C, D). Spheroids cultured in diﬀerentiation medium with EP4 inhibitor (DM+EP4i) or treated with cycloheximide and
tumor necrosis factor (CHX+TNF) served as negative controls. The positive control for LDH (LDH+) was provided with the assay kit. (A, B) Graphs of CellTiter-Glo
data presented as fold change (mean ± s.e.m.) relative to the average Stappenbeck CM value; n= 3 independent experiments. (C, D) Graphs of LDH levels detected
in spheroid culture supernatants presented as fold change (mean ± s.e.m.) relative to the average Stappenbeck CM value; n= 3 independent experiments. (E)
Graphs of LDH levels detected in L-WRN CM batches presented as fold change (mean ± s.e.m.) relative to the average Stappenbeck CM value; n= 3 technical
replicates. **P < 0.01, ****P < 0.0001 by 1-way ANOVA and Dunnett's post test relative to the average Stappenbeck CM value (represented by dashed line).
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assays is that these cells are relatively more diﬃcult to culture than
transformed or immortalized cell lines, with results being highly de-
pendent on the technical skill of the individual performing the proce-
dures. Circumventing the requirement for technical expertise in orga-
noid or spheroid culture for CM quality control procedures would be
helpful, especially for laboratories new to these techniques. Other
groups have reported using transformed cell lines expressing the Wnt-
sensitive TOP-Flash/FOP-Flash luciferase reporters or expressing a
stable Wnt TCF/LEF reporter for quality control testing of R spondin CM
and Wnt3a CM (Gunasekara et al., 2018; Holly and Smith, 2018; Wang
et al., 2017). For these reasons, we also explored the use of a Wnt re-
porter cell line for quality control testing of L-WRN CM. We observed
robust Wnt reporter induction in response to L-WRN CM treatment, as
expected. However, similar reporter induction was observed in L-WRN
CM batches that supported spheroid growth (i.e. CM1–13) and one that
did not (i.e. the TE batch). We also observed similar Axin2 mRNA gene
expression between these batches, further supporting the equivalency
of Wnt-stimulating activity between batches of L-WRN CM of highly
variable quality. We conclude that it is insuﬃcient to solely rely on the
use of Wnt reporter cells to assess L-WRN CM quality; clearly other
medium factors can have dominant eﬀects on spheroid growth. Other
laboratory groups have also employed enzyme-linked immunosorbent
assays or Western blotting to quantify secreted protein levels of Wnt3a
and Noggin in single factor CM (Gunasekara et al., 2018; Holly and
Smith, 2018; Wang et al., 2017). We attempted to perform direct pro-
tein quantiﬁcation using L-WRN CM but were unsuccessful, likely due
to the serum levels in the medium.
In this study, we found that qualitative and quantitative measures of
spheroid growth and proliferation were best able to discriminate be-
tween high-quality and low-quality batches of L-WRN CM. Inspection of
spheroid visual characteristics and growth by microscopy can be very
useful, but requires technical experience and can introduce individual
bias. Thus, in addition to careful visual inspection of spheroids, we
recommend incorporating two relatively simple quantitative assays into
the L-WRN CM quality control procedure. First, we recommend per-
forming an assay for cell growth and viability, such as the CellTiter-Glo
Fig. 5. Reproducible spheroid mRNA marker expression across multiple L-WRN CM batches.
(A-D) Mouse or human colonic spheroids were cultured in CM1–13 or TE batches of L-WRN CM followed by qPCR assessment of relative mRNA abundance of Lgr5
(A), MKi67 (B), Axin2 (C), and Car1 (D). Spheroids cultured in diﬀerentiation medium with EP4 inhibitor (DM+EP4i) served as a control. Graphs of mRNA
expression data are presented as fold change (mean ± s.e.m.) relative to the average Stappenbeck CM value; n= 3 independent experiments. *P < 0.05,
**P < 0.01, ****P < 0.0001 by 1-way ANOVA and Dunnett's post test relative to the average Stappenbeck CM value (represented by dashed line); n.d., not
detected.
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assay used in this study. Quantitative spheroid growth should be similar
when comparing new batches of L-WRN CM to previous batches known
to support spheroid growth. (or higher in the new batch, which has
been stored for a lesser amount of time). If a previous batch of high-
quality L-WRN CM is not available, perform the assay on sequential
days (e.g. spheroids seeded on Day 0 and then assayed on Days 1, 2, and
3 post-seeding) to assess the spheroid growth rate over time
(VanDussen et al., 2015). Alternatively, cell cycle analysis (e.g., EdU
incorporation followed by ﬂow cytometry) can be used to determine the
proportion of cells in S-phase, which should match published results
(VanDussen et al., 2015; Kaiko et al., 2016; Sun et al., 2015). Second,
we recommend performing qPCR analysis of a small panel of gene
markers for tissue-speciﬁc stem cells, proliferating cells, and diﬀer-
entiating cells (e.g. Lgr5, MKi67, and Car1 for colonic spheroids). The
diﬀerentiation medium used as a control is entirely composed of com-
mercially available reagents and therefore should be replicable across
laboratory groups. Good quality L-WRN CM will yield spheroids with
high levels of stem and proliferation markers and low-to-absent levels
of diﬀerentiation markers. A summary of the expected results for the
quality control assays in this study are provided in Supplementary
Table S3. Common problems encountered by investigators using L-WRN
CM and the associated trouble-shooting solutions are provided in
Supplementary Table S4.
We uncovered some aspects of L-WRN CM batch variation in this
study that would be important to consider for particular experiments.
Although we did not detect any diﬀerences in spheroid growth between
L-WRN CM collected on Days 1–4 vs. Days 5–8, we did observe lower
Wnt-stimulating activity in Days 5–8 L-WRN CM. Accordingly, studies
investigating Wnt signaling should use L-WRN CM from a single col-
lection period. We also observed high levels of LDH in one batch of L-
WRN CM that apparently supported normal spheroid growth. If high
LDH levels are observed in a L-WRN CM batch, it is possible that other
factors associated with cellular damage are also present in that batch.
These potentially could aﬀect the results of certain experiments, such as
those examining cell death. Together, these results indicate that study-
speciﬁc quality control procedures for L-WRN CM may need to be
performed to ensure reproducible results for particular experiments.
The basic and translational research applications for primary gas-
trointestinal epithelial cells will continue to rapidly expand as more and
more laboratories adopt these culture platforms for their research
(Clevers, 2016; Nakamura and Sato, 2018; Huch et al., 2017). Con-
comittant with this expansion will come many variations on medium
composition, culture techniques, and reagent sources, all of which can
aﬀect experimental outcomes with cultured primary gastrointestinal
epithelium. Thus, it is critical that investigators provide detailed
methods that enable critical review and experimental replicability (e.g.
see refs (Gunasekara et al., 2018; Holly and Smith, 2018; Wang et al.,
2017)). We undertook this study to provide a transparent report of the
batch-to-batch variation of L-WRN CM and recommend quality control
procedures. We propose that these types of quality control procedures
should be adopted as standard operating procedures for any laboratory
group using CM (L-WRN or otherwise) and should be reported in ex-
perimental methods sections of publications. Implementation of robust
quality control measures will reduce resource waste and improve the
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Fig. 6. Reproducible spheroid proliferation across multiple L-WRN CM batches.
(A) Schematic of experimental time line for the Cdc25A-CBRluc assay. Mouse
Cdc25A-CBRluc spheroids were cultured in CM1–13 or TE batches of L-WRN
CM or in diﬀerentiation medium with EP4 inhibitor (DM+EP4i) as a negative
control for proliferation. (B) Graphs of Cdc25A-CBRluc luminescence of data
normalized to the average 0 h value for all samples per experiment and pre-
sented as fold change (mean ± s.e.m.) relative to the average Stappenbeck CM
value (Average TSS; shown in lower graph); n=3 independent experiments.
The samples in the upper and lower graphs were run in the same experiments
but are presented in two graphs for allow for discrimination of individual
curves. *P < 0.05 by 2-way repeated measures ANOVA and Dunnett's post test
relative to average Stappenbeck CM.
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